Clinical Trials Directory

Trials / Completed

CompletedNCT00864006

Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions

A Single-Dose, Comparative Bioavailability Study of Two Formulations of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Sandoz · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to demonstrate the bioequivalence of divalproex sodium 125 MG delayed release tablets.

Conditions

Interventions

TypeNameDescription
DRUGDivalproex Sodium
DRUGDepakote DR Tablets

Timeline

Start date
2006-10-01
Primary completion
2006-10-01
Completion
2006-10-01
First posted
2009-03-18
Last updated
2017-03-29

Source: ClinicalTrials.gov record NCT00864006. Inclusion in this directory is not an endorsement.

Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions (NCT00864006) · Clinical Trials Directory